Suzetrigine Patent Expiration

Suzetrigine was first introduced by Vertex Pharmaceuticals Inc in its drug Journavx on Jan 30, 2025.

Suzetrigine Patents

Given below is the list of patents protecting Suzetrigine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Journavx	US11834441	Substituted tetrahydrofurans as modulators of sodium channels	Dec 04, 2040	Vertex Pharms Inc

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List